Gossamer Bio Inc (GOSS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3013 SCIENCE PARK SAN DIEGO, CA 92121

Gossamer Bio, Inc. operates as a biopharmaceutical company. The Company focuses on discovering, acquiring, and developing therapeutics in the disease areas of immunology, inflammation, and oncology. Gossamer Bio serves customers in the United States.

Data based on most recent fiscal year report
Market Cap922.579 Million Shares Outstanding66.04 Million Avg Volume511.153 Thousand
1-Yr BETA vs S&P TR0.768 Current Ratio11.37 Quick Ratio11.37

Are you looking for this stock instead?

View SEC Filings from GOSS instead.

View recent insider trading info

Funds Holding GOSS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GOSS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SALTER-CID LUISA CHIEF SCIENTIFIC OFFICER

  • Officer
166,556 2020-02-14 3

GIRAUDO BRYAN CHIEF FINANCIAL OFFICER

  • Officer
72,500 2020-02-14 2

GUJRATHI SHEILA PRESIDENT & CEO

  • Officer
  • Director
4,237,742 2020-02-14 2

CHRISTIAN WAAGE EVP & GENERAL COUNSEL

  • Officer
574,674 2020-02-14 2

DUPONT JAKOB CHIEF MEDICAL OFFICER

  • Officer
46,500 2020-02-14 2

HASNAIN FAHEEM

3,000 2020-01-03 1

OMEGA FUND V, L.P.

OMEGA FUND V GP, L.P.

OMEGA FUND V GP MANAGER, LTD.

  • 10% Owner
6,553,416 2019-09-20 1

OMEGA FUND V, L.P.

OMEGA FUND V GP, L.P.

OMEGA FUND V GP MANAGER, LTD.

STAMPACCHIA OTELLO

  • 10% Owner
  • FORMER DIRECTOR.
6,737,023 2019-09-16 2

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GUJRATHI SHEILA - Director - Officer PRESIDENT & CEO

2020-02-14 A 189,500 a 189,500 4,237,742.00 direct

SALTER-CID LUISA - Officer CHIEF SCIENTIFIC OFFICER

2020-02-14 A 46,500 a 166,556 166,556.00 direct

DUPONT JAKOB - Officer CHIEF MEDICAL OFFICER

2020-02-14 A 71,500 a 71,500 46,500.00 direct

CHRISTIAN WAAGE - Officer EVP & GENERAL COUNSEL

2020-02-14 A 46,500 a 547,998 574,674.00 direct

GIRAUDO BRYAN - Officer CHIEF FINANCIAL OFFICER

2020-02-14 A 71,500 a 71,500 72,500.00 direct

DUPONT JAKOB - Officer CHIEF MEDICAL OFFICER

2020-02-14 A 46,500 a 46,500 46,500.00 direct

GUJRATHI SHEILA - Director - Officer PRESIDENT & CEO

2020-02-14 A 292,000 a 292,000 4,237,742.00 direct

SALTER-CID LUISA - Officer CHIEF SCIENTIFIC OFFICER

2020-02-14 A 71,500 a 71,500 166,556.00 direct

GIRAUDO BRYAN - Officer CHIEF FINANCIAL OFFICER

2020-02-14 A 46,500 a 70,379 72,500.00 direct

CHRISTIAN WAAGE - Officer EVP & GENERAL COUNSEL

2020-02-14 A 71,500 a 71,500 574,674.00 direct

Elevate your investments